Key Publications
Risk of breast cancer according to the status of HER-2/neu oncogene amplification. Kathleen Conway, Wen-Yi Huang, Barbara Hulka, Edison Liu, Robert Millikan, Beth Newman, Michael Schell (2000). Cancer Epidemiology Biomarkers and Prevention, 9(1), 65-71.
HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. et al., Kathleen Conway, Barbara Hulka, L. III, Scott Joens, Edison Liu, Debra Novotny, Michael Schell, Azadeh Stark, Ann Thor, Lester Wold (2000). Journal of Clinical Oncology, 18(2), 267-274.
P57 (KIP2) polymorphisms and breast cancer risk. Kathleen Conway, Yu Li, Edison Liu, Robert Millikan, Beth Newman, Chiu-Kit Tse (1999). Human Genetics, 104(1), 83-88.
p53 Mutations in head and neck cancer: New data and evaluation of mutational spectra. Kathleen Conway, Andrew Olshan, Hong Pei, Mark Weissler (1997). Cancer Epidemiology Biomarkers and Prevention, 6(7), 499-504.
Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures. Kathleen Conway, Daniel Gioeli, Bernard Weissman (1997). Cancer Research, 57(6), 1157-1165.
Education
- PhD, Environmental Health Science, New York University, 1989
- BS, Biology, University of Notre Dame, 1978
